LENZ Therapeutics, Inc. (LENZ) Return on Capital Employed (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Return on Capital Employed for 2 consecutive years, with 0.3% as the latest value for Q3 2023.
LENZ Therapeutics (LENZ) has disclosed Return on Capital Employed for 2 consecutive years, with 0.3% as the latest value for Q3 2023.